Bringing Pharmacogenomics to Mainstream Medicine

Mark Bartlett is an expert in pharmacogenomics, the study of how a person’s genes affect their response to drugs. He is also the founder of the health startup Geneix, which was named ‘Most Disruptive Startup’ in 2014 by TechCity News. Geneix has been trying to bring the use of pharmacogenomics into mainstream healthcare.

Mark talked to me about his vision of using pharmacogenomic data in everyday health settings to decrease adverse drug reactions and thus improve patient safety, the large scale impact this could potentially have on our health, as well as the huge challenges facing startups like Geneix in introducing an innovative product into the health care market.

You can find out more about Geneix at and you can follow Mark on twitter at @Mark_Geneix